Merck, Gnosis Settle Vitamin False Marketing Case
Merck Eprova and rival pharmaceutical company Gnosis SpA have settled a false advertising and unfair competition suit alleging that Gnosis violated the Lanham Act when it falsely portrayed its folate-producing compound...To view the full article, register now.
Already a subscriber? Click here to view full article